Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
An update from Cann Group Ltd. ( (AU:CAN) ) is now available.
Cann Group Ltd. has announced the application for quotation of 41,876,573 ordinary fully paid securities on the Australian Securities Exchange (ASX) as part of a previously announced transaction. This move is expected to enhance the company’s capital structure, potentially improving its market position and providing greater value to its stakeholders.
More about Cann Group Ltd.
Cann Group Ltd. operates in the pharmaceutical industry, focusing on the cultivation and production of medicinal cannabis products. The company is engaged in developing cannabis-based therapies and has a market focus on providing innovative healthcare solutions.
YTD Price Performance: 100%
Average Trading Volume: 200
Technical Sentiment Signal: Strong Buy
Current Market Cap: $6M
For detailed information about CAN stock, go to TipRanks’ Stock Analysis page.